Chemoinformaics analysis of Maclurin 3-C-(6”-O-p-hydroxybenzoyl)?-D-glucoside
Molecular Weight | 544.465 | nRot | 6 |
Heavy Atom Molecular Weight | 520.273 | nRig | 26 |
Exact Molecular Weight | 544.122 | nRing | 4 |
Solubility: LogS | -3.535 | nHRing | 1 |
Solubility: LogP | 1.66 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 63 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 39 | No. of Aromatic Carbocycles | 3 |
nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 26 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
No. of Oxygen atom | 13 | No. of Arom Bond | 18 |
nHA | 13 | APOL | 69.849 |
nHD | 9 | BPOL | 29.285 |
QED | 0.117 |
Synth | 4.053 |
Natural Product Likeliness | 1.478 |
NR-PPAR-gamma | 0.926 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.005 |
Pgp-sub | 0.014 |
HIA | 0.894 |
CACO-2 | -6.537 |
MDCK | 0.00000477 |
BBB | 0.02 |
PPB | 0.988172 |
VDSS | 0.557 |
FU | 0.0384336 |
CYP1A2-inh | 0.084 |
CYP1A2-sub | 0.017 |
CYP2c19-inh | 0.033 |
CYP2c19-sub | 0.038 |
CYP2c9-inh | 0.291 |
CYP2c9-sub | 0.291 |
CYP2d6-inh | 0.061 |
CYP2d6-sub | 0.154 |
CYP3a4-inh | 0.12 |
CYP3a4-sub | 0.023 |
CL | 8.808 |
T12 | 0.833 |
hERG | 0.033 |
Ames | 0.64 |
ROA | 0.041 |
SkinSen | 0.603 |
Carcinogencity | 0.108 |
EI | 0.658 |
Respiratory | 0.007 |
NR-Aromatase | 0.879 |
Antiviral | Yes |
Prediction | 0.936852 |